University of Sydney will use AI to boost cancer drug research
Pharmaceutical Technology
MAY 31, 2023
A subsidiary of South Korean pharmaceutical company Pharos iBio, Pharos will give the university’s drug discovery initiatives team access to Pharos iBio’s AI drug development platform, which is called Chemiverse. It will provide the drug discovery initiative access to advanced algorithms and 230 million big data entries.
Let's personalize your content